Science Explorer Back to mapMap
Discussion
Company · Vancouver · Canada

Vancouver Biotech (Canada)

In research, Vancouver Biotech (Canada) stands highest in Health Sciences (#3,476 of 16,688 worldwide), Medicine (#3,454 of 14,558 worldwide) and Social Sciences (#4,201 of 14,833 worldwide), over all time.

World rank, 2022-now
#21,438
of 22,385 · #3,439 all time
Rank in Canada
#297
of 305
Research works
499
▼ 22% vs 2018-21
Citations
7.7k
15.4 per fractional work
Top-10% rate
13.0%
all institutions 10.0%
vs its own fields
0.92×
1.00× is exactly expected
Open access
49%
world 40%
International
17%
world 18%

What is Vancouver Biotech (Canada) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #3,476 of 16,688 8.3%191
MedicineField #3,454 of 14,558 8.7%165
Social SciencesDomain #4,201 of 14,833 11.2%121

Each strip is that field's whole ranked pool, with the notch where Vancouver Biotech (Canada) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Vancouver Biotech (Canada) work in?

In 2022-now, 67% of research at Vancouver Biotech (Canada) is in Health Sciences, 23% in Life Sciences. Its largest fields are Medicine (64%), Biochemistry, Genetics and Molecular Biology (16%), Immunology and Microbiology (4%). It does 2.7× the world's share of Health Sciences.

Health Sciences: 62 fractional works · 67.1% of its workMedicine: 60 fractional works · 64.3% of its workNeurology: 15 fractional works · 16.3% of its workEpidemiology: 7 fractional works · 7.9% of its workSurgery: 6 fractional works · 6.5% of its workPublic Health, Environmental and Occupational Health: 6 fractional works · 6.0% of its workPulmonary and Respiratory Medicine: 3 fractional works · 3.3% of its workGenetics: 3 fractional works · 3.3% of its workPsychiatry and Mental health: 3 fractional works · 2.8% of its workPathology and Forensic Medicine: 3 fractional works · 2.8% of its workOncology: 2 fractional works · 2.6% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 2.3% of its workReproductive Medicine: 2 fractional works · 1.7% of its workPediatrics, Perinatology and Child Health: 2 fractional works · 1.7% of its workEmergency Medicine: 1 fractional works · 1.6% of its workPhysiology: 1 fractional works · 1.1% of its workRheumatology: 1 fractional works · 1.1% of its workInfectious Diseases: 1 fractional works · 1.0% of its workRehabilitation: 0 fractional works · 0.5% of its workImmunology and Allergy: 0 fractional works · 0.4% of its workObstetrics and Gynecology: 0 fractional works · 0.4% of its workOphthalmology: 0 fractional works · 0.4% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.6% of its workHealth Professions: 3 fractional works · 2.7% of its workGeneral Health Professions: 2 fractional works · 2.1% of its workPharmacy: 0 fractional works · 0.4% of its workSpeech and Hearing: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workLife Sciences: 21 fractional works · 22.8% of its workBiochemistry, Genetics and Molecular Biology: 15 fractional works · 15.7% of its workGenetics: 6 fractional works · 6.9% of its workMolecular Biology: 5 fractional works · 5.4% of its workBiotechnology: 2 fractional works · 1.9% of its workClinical Biochemistry: 1 fractional works · 0.7% of its workCancer Research: 0 fractional works · 0.4% of its workCell Biology: 0 fractional works · 0.4% of its workImmunology and Microbiology: 3 fractional works · 3.7% of its workImmunology: 2 fractional works · 2.3% of its workParasitology: 0 fractional works · 0.5% of its workMicrobiology: 0 fractional works · 0.5% of its workVirology: 0 fractional works · 0.5% of its workAgricultural and Biological Sciences: 1 fractional works · 1.6% of its workAnimal Science and Zoology: 1 fractional works · 0.8% of its workPlant Science: 0 fractional works · 0.4% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 1 fractional works · 1.4% of its workCognitive Neuroscience: 0 fractional works · 0.4% of its workDevelopmental Neuroscience: 0 fractional works · 0.4% of its workNeurology: 0 fractional works · 0.4% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.4% of its workSocial Sciences: 6 fractional works · 6.9% of its workSocial Sciences: 2 fractional works · 2.7% of its workHealth: 2 fractional works · 1.6% of its workGender Studies: 1 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.2% of its workBusiness, Management and Accounting: 2 fractional works · 1.8% of its workOrganizational Behavior and Human Resource Management: 1 fractional works · 1.4% of its workStrategy and Management: 0 fractional works · 0.4% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.3% of its workEconomics and Econometrics: 1 fractional works · 1.3% of its workPsychology: 1 fractional works · 1.2% of its workExperimental and Cognitive Psychology: 1 fractional works · 0.8% of its workClinical Psychology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysical Sciences: 3 fractional works · 3.3% of its workEngineering: 1 fractional works · 1.4% of its workBiomedical Engineering: 0 fractional works · 0.4% of its workMechanical Engineering: 0 fractional works · 0.4% of its workAutomotive Engineering: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.4% of its workComputer Science: 1 fractional works · 0.7% of its workArtificial Intelligence: 0 fractional works · 0.4% of its workComputational Theory and Mathematics: 0 fractional works · 0.4% of its workEnvironmental Science: 1 fractional works · 0.7% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMaterials Science: 0 fractional works · 0.3% of its workMaterials Chemistry: 0 fractional works · 0.3% of its workEarth and Planetary Sciences: 0 fractional works · 0.1% of its workALL ITS WORKVancouver Biotech(Canada)93fractional works, 2022-now
Life Sciences23%Physical Sciences3%Health Sciences67%Social Sciences7%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 16 fields, with their numbers
    1. Medicine6064.3%
    2. Health Professions32.7%
    1. Biochemistry, Genetics and Molecular Biology1515.7%
    2. Immunology and Microbiology33.7%
    3. Agricultural and Biological Sciences11.6%
    4. Neuroscience11.4%
    5. Pharmacology, Toxicology and Pharmaceutics00.4%
    1. Social Sciences22.7%
    2. Business, Management and Accounting21.8%
    3. Economics, Econometrics and Finance11.3%
    4. Psychology11.2%
    1. Engineering11.4%
    2. Computer Science10.7%
    3. Environmental Science10.7%
    4. Materials Science00.3%
    5. Earth and Planetary Sciences00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.34× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.94× its world share, 15 worksBiochemistry, Geneti…Immunology and Microbiology: 3.71× its world share, 4 worksImmunology and Micro…Neuroscience: 0.86× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.02× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.09× its world share, 1 worksComputer ScienceEarth and Planetary Sciences: 0.06× its world share, 0 worksEarth and Planetary …Engineering: 0.10× its world share, 1 worksEngineeringEnvironmental Science: 0.14× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.09× its world share, 0 worksMaterials ScienceHealth Professions: 1.04× its world share, 3 worksHealth ProfessionsMedicine: 3.35× its world share, 60 worksMedicineBusiness, Management and Accounting: 0.56× its world share, 2 worksBusiness, Management…Economics, Econometrics and Finance: 0.59× its world share, 1 worksEconomics, Econometr…Psychology: 0.38× its world share, 1 worksPsychologySocial Sciences: 0.21× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 3.7×. Every wedge is a field page.

All 16 fields, with their numbers
  1. Immunology and Microbiology3.71×4 works
  2. Medicine3.35×60 works
  3. Biochemistry, Genetics and Molecular Biology2.94×15 works
  4. Health Professions1.04×3 works
  5. Pharmacology, Toxicology and Pharmaceutics1.02×0 works
  6. Neuroscience0.86×1 works
  7. Economics, Econometrics and Finance0.59×1 works
  8. Business, Management and Accounting0.56×2 works
  9. Psychology0.38×1 works
  10. Agricultural and Biological Sciences0.34×2 works
  11. Social Sciences0.21×2 works
  12. Environmental Science0.14×1 works
  13. Engineering0.10×1 works
  14. Computer Science0.09×1 works
  15. Materials Science0.09×0 works
  16. Earth and Planetary Sciences0.06×0 works

Who are the top researchers at Vancouver Biotech (Canada)?

Ranked on the quality score, Ronghua Zhao, Jun Ding and Yanal M. Murad lead among researchers whose main affiliation is Vancouver Biotech (Canada).

  1. 1 Ronghua Zhao Canada · #804,893 worldwide 1.3k citations · 49 works
  2. 2 Jun Ding Canada · #1,072,741 worldwide 274 citations · 25 works
  3. 3 Yanal M. Murad Canada · #1,479,266 worldwide 897 citations · 38 works
  4. 4 Kay Cahill Canada · #1,691,075 worldwide 134 citations · 15 works
  5. 5 S. Mack Eastman Canada · #1,775,240 worldwide 179 citations · 69 works
  6. 6 Robin McKie Canada · #4,151,762 worldwide 55 citations · 21 works
  7. 7 William E. Fredeman Canada · #4,318,455 worldwide 70 citations · 52 works
  8. 8 Heather Kent Canada · #5,376,201 worldwide 813 citations · 122 works
  9. 9 D. Gray-Grant Canada · #5,873,130 worldwide 34 citations · 46 works
All ranked researchers at Vancouver Biotech (Canada)

What are the most cited papers from Vancouver Biotech (Canada)?

The most cited paper from Vancouver Biotech (Canada) is "A review of electrolyte materials and compositions for electrochemical supercapacitors" (Cheng Zhong, Yida Deng, Wenbin Hu et al., 2015), with 3,687 citations. Next come "International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology" (1,463) and "Sustainable carbon materials" (1,273).

Most cited papers
#PaperReleasedCitations
1 A review of electrolyte materials and compositions for electrochemical supercapacitors Cheng Zhong, Yida Deng, Wenbin Hu et al. · Chemical Society Reviews Review 2015 3,687
2 International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology Kim Solez et al. · Kidney International Open access Aug 1993 1,463
3 Sustainable carbon materials Maria‐Magdalena Titirici, Robin J. White, Nicolas Brun et al. · Chemical Society Reviews Review 10 Oct 2014 1,273
4 Semiconductor polymeric graphitic carbon nitride photocatalysts: the “holy grail” for the photocatalytic hydrogen evolution reaction under visible light Guangfu Liao, Yan Gong, Li Zhang et al. · Energy & Environmental Science 2019 1,087
5 Current characterization methods for cellulose nanomaterials Earl Johan Foster et al. · Chemical Society Reviews ReviewOpen access 2018 1,036
All 60 most cited papers, with filters and sorting

Which keywords describe research at Vancouver Biotech (Canada)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Immunotherapy, Epidemiology, Genetic Mutations, Gene Therapy, Radiotherapy, Radiosurgery, Prognosis and Surgical Management.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology13▲ 3.4×24 topics
  2. Immunotherapy9▲ 14×8 topics
  3. Genetic Mutations7▲ 16×7 topics
  4. Gene Therapy6▲ 33×3 topics
  5. Radiotherapy6▲ 16×5 topics
  6. Radiosurgery5▲ 63×3 topics
  7. Prognosis5▲ 17×5 topics
  8. Surgical Management5▲ 13×5 topics
  9. Public Health5▲ 3.7×9 topics
  10. Neurological Disorders5▲ 9.1×8 topics
  11. Prognostic Factors4▲ 11×2 topics
  12. Inflammation4▲ 2.0×9 topics
  13. Autoantibodies4▲ 17×5 topics
  14. Treatment4▲ 3.2×9 topics
  15. Genomic Analysis4▲ 15×2 topics
  16. AAV3▲ 87×1 topic
  17. Histological Classification3▲ 113×1 topic
  18. Meningiomas3▲ 113×1 topic
  19. Vaccine3▲ 8.6×5 topics
  20. Viral Vectors3▲ 87×1 topic
  21. Clinical Trials3▲ 4.8×7 topics
  22. Pathogenesis3▲ 6.2×4 topics
  23. Immune Response3▲ 5.2×4 topics
  24. Tumor Regression3▲ 27×2 topics
  25. Clinical Management3▲ 16×4 topics
  26. Molecular Classification3▲ 18×2 topics
  27. Neuroprotection3▲ 7.9×3 topics
  28. Glioblastoma2▲ 39×1 topic
  29. Temozolomide2▲ 39×1 topic
  30. Diagnostic Criteria2▲ 11×4 topics
  31. Endovascular Treatment2▲ 41×2 topics
  32. Epilepsy2▲ 21×2 topics
  33. Intravenous Immunoglobulin2▲ 37×2 topics
  34. Quality Assessment2▲ 13×2 topics
  35. Clinical Guidelines2▲ 7.8×1 topic
  36. Guideline Development2▲ 118×1 topic
  37. Neurofibromatosis2▲ 115×1 topic
  38. Tumor Suppressor2▲ 54×1 topic
  39. Antiepileptic Drugs2▲ 28×2 topics
  40. Cognitive Impairment2▲ 8.5×4 topics

Which research topics does Vancouver Biotech (Canada) publish most on?

By volume in 2022-now: Meningioma and schwannoma management, Virus-based gene therapy research, Glioma Diagnosis and Treatment and Neurofibromatosis and Schwannoma Cases.

  1. 1 Meningioma and schwannoma management Epidemiology 3 works
  2. 2 Virus-based gene therapy research Genetics 3 works
  3. 3 Glioma Diagnosis and Treatment Genetics 2 works
  4. 4 Neurofibromatosis and Schwannoma Cases Neurology 2 works
  5. 5 Clinical practice guidelines implementation Public Health, Environmental and Occupational Health 2 works
  6. 6 Epilepsy research and treatment Psychiatry and Mental health 2 works
  7. 7 Cancer Research and Treatments Biotechnology 2 works
  8. 8 Vascular Malformations Diagnosis and Treatment Neurology 2 works
  9. 9 Peripheral Neuropathies and Disorders Neurology 2 works
  10. 10 Trauma and Emergency Care Studies Emergency Medicine 2 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.4%not open50.6%

World: 40% of research is openly available.

with international co-authors17.0%domestic only83.0%

World: 18% is written across borders.

How has Vancouver Biotech (Canada)'s research output changed?

Output in 2022-2025 was 22% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Vancouver Biotech (Canada) as a percentage of every work published that year, 0.00054% in 2024.

still counting0.0010%0.0020%Vancouver Biotech (Canada)0.00045% in 202519801990200020102020

Fractional works of Vancouver Biotech (Canada) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

still counting5%10%15%Vancouver Biotech (Canada)13.0% in 2025all institutions10.0% in 20252020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 13.0% in 2025.

Other research institutions in Vancouver

All research institutions in Vancouver

Share Vancouver Biotech (Canada)'s ranking

Vancouver Biotech (Canada) on Science Explorer

A card with Vancouver Biotech (Canada)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Vancouver Biotech (Canada). Posts are plain text and can be reported.